Literature DB >> 10622253

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.

N Prenzel1, E Zwick, H Daub, M Leserer, R Abraham, C Wallasch, A Ullrich.   

Abstract

Cross-communication between different signalling systems allows the integration of the great diversity of stimuli that a cell receives under varying physiological situations. The transactivation of epidermal growth factor receptor (EGFR)-dependent signalling pathways upon stimulation of G-protein-coupled receptors (GPCRs), which are critical for the mitogenic activity of ligands such as lysophosphatidic acid, endothelin, thrombin, bombesin and carbachol, provides evidence for such an interconnected communication network. Here we show that EGFR transactivation upon GPCR stimulation involves proHB-EGF and a metalloproteinase activity that is rapidly induced upon GPCR-ligand interaction. We show that inhibition of proHB-EGF processing blocks GPCR-induced EGFR transactivation and downstream signals. The pathophysiological significance of this mechanism is demonstrated by inhibition of constitutive EGFR activity upon treatment of PC3 prostate carcinoma cells with the metalloproteinase inhibitor batimastat. Together, our results establish a new mechanistic concept for cross-communication among different signalling systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622253     DOI: 10.1038/47260

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  443 in total

1.  GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways.

Authors:  X Lou; H Yano; F Lee; M V Chao; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

2.  A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away.

Authors:  N M Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.

Authors:  Michael D Schneider
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 4.  Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Authors:  Mariana M Belcheva; Carmine J Coscia
Journal:  Neurosignals       Date:  2002 Jan-Feb

5.  Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis.

Authors:  S M Knox; I M A Lombaert; X Reed; L Vitale-Cross; J S Gutkind; M P Hoffman
Journal:  Science       Date:  2010-09-24       Impact factor: 47.728

6.  Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation.

Authors:  Fan Zhang; Hua Yang; Zan Pan; Zheng Wang; J Mario Wolosin; Per Gjorstrup; Peter S Reinach
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

7.  Urea signalling to immediate-early gene transcription in renal medullary cells requires transactivation of the epidermal growth factor receptor.

Authors:  Hongyu Zhao; Wei Tian; Hongshi Xu; David M Cohen
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

8.  Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.

Authors:  Seok Jin Kim; Zahid N Rabbani; Fan Dong; Robin T Vollmer; Ernst-Gilbert Schreiber; Mark W Dewhirst; Zeljko Vujaskovic; Michael J Kelley
Journal:  Med Oncol       Date:  2009-02-24       Impact factor: 3.064

9.  Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.

Authors:  Mazin A Al-Salihi; Scott C Ulmer; Thao Doan; Cory D Nelson; Tracy Crotty; Stephen M Prescott; Diana M Stafforini; Matthew K Topham
Journal:  Cell Signal       Date:  2007-05-23       Impact factor: 4.315

Review 10.  Gastrin: old hormone, new functions.

Authors:  Graham Dockray; Rod Dimaline; Andrea Varro
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.